Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at http://www.icmje.org/recommendations/). 

Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information Authors, Readers and Editors may visit the COPE website: http://publicationethics.org/.

Charges for manuscript publication

The cost of publication of accepted manuscript is 1200 Euro.

Organization of manuscript

The first page must include:

• the title,
• name(s) of author(s),
• affiliation(s),
• short running head (no more than 60 characters incl. spaces)
• and detailed address for correspondence including e-mail.

Organization of the manuscript:

1. Abstract (not exceeding one typed page) - should consist of the following sections: Introduction, Material and methods, Results, Conclusions;
2. Key words - max. 10;
3. Introduction;
4. Material and methods;
5. Results;
6. Discussion;
7. Acknowledgements (if any);
8. References;
9. Tables (with legends);
10. Figures;
11. Legends to figures.

In a short communication, Results and Discussion should be written jointly. Organization of a review article is free.

In References section of article please use Vancuver citation style:

Notes:

• Items are listed numerically in the order they are cited in the text, not alphabetically.
• Authors: use initials of first and second names with no spaces, include the first three, followed by et  al. If no author is given, start with the title.
• Books: include the edition statement (ex: 3rd ed. or Rev ed.) between the title and place if it is not the first edition.
• Place: use abbreviations of states, not postal codes.
• Journals: abbreviate titles as shown in Index Medicus.
• Websites: include the name of the webpage, the name of the entire website, the full date of the page (if available), and the date you looked at it.
• The rules concerning a title within a title are not displayed here for purposes of clarity. See the printed version of the manual for details.
• For documents and situations not listed here, see the printed version of the manual. A similar styleguide is the Uniform Requirements for Manuscripts Submitted to Biomedical Journals

Book

1.  Okuda M, Okuda D. Star Trek Chronology: The History of the Future.
New York: Pocket Books; 1993.

Journal or Magazine Article 

2.  Redon J, Cifkova R, Laurent S et al. Mechanisms of hypertension
in the cardiometabolic syndrome. J Hypertens 2009;27:441–451.
doi: 10.1097/HJH.0b013e32831e13e5.

Encyclopedia Article

3.  Sturgeon T. Science fiction. In: Lorimer LT, editorial director;
Cummings C, ed-in-chief; Leish KW, managing ed. The Encyclopedia
Americana. Vol 24. International ed. Danbury, Conn: Grolier
Incorporated; 1995:390-392.

Book Article or Chapter

4.  James NE. Two sides of paradise: the Eden myth according to Kirk
and Spock. In: Palumbo D, ed. Spectrum of the Fantastic. Westport,
Conn: Greenwood; 1988:219-223.

When the manufacturers of the reagents etc. are mentioned for the first time, town, (state in the US) and country must be provided wheras for next referral only the name of the firm should be given.

ERIC Document

5.  Fuss-Reineck M. Sibling Communication in Star Trek: The Next
Generation: Conflicts Between Brothers. Miami, Fla: Annual Meeting
of the Speech Communication Association; 1993. ERIC Document
Reproduction Service ED364932.

Website

6.  Lynch T. DSN trials and tribble-ations review. Psi Phi: Bradley's
Science Fiction Club Web site. 1996. Available at:
http://www.bradley.edu/campusorg/psiphi/DS9/ep
/503r.htm. Accessed October 8, 1997.

Journal Article on the Internet

7.  McCoy LH. Respiratory changes in Vulcans during pon farr. J Extr
Med [serial online]. 1999;47:237-247. Available at:
http://infotrac.galegroup.com/itweb/nysl_li_liu. Accessed April 7,
1999.

Technical requirements

Illustrations (line drawings and halftones) - either single or mounted in the form of plates, can be 85 mm, 125 mm, or 175 mm wide and cannot exceed the size of 175 x 250 mm. The authors are requested to plan their illustrations in such a way that the printed area is economically used. Numbers, inscriptions and abbreviations on the figures must be about 3 mm high. In case of micrographs, magnification (e.g. x 65 000) should be given in the legend. Calibration bars can also be used.

For the best quality of ilustrations please provide images in one of commonly used formats e.g. *.tiff , *.png, *.pdf (preferred resolution 300dpi).



Tables should be numbered consecutively in arabic numerals and each table must be typed on a separate page. The authors are requested to mark the places in the text, where a given table or figure should appear in print.

Legends must begin on a new page and should be as concise as necessary for a self-sufficient explanation of the illustrations.

PDF file of each paper is supplied free of charge.

Author’s statement

The manuscript must be accompanied by the author's statement that it has not been published (or submitted to publication) elsewhere.

Authorship

All collaborators who have made significant and substantial contributions to a study are considered coauthors. The nature and level of contribution of all authors of accepted manuscripts must be indicated, i.e. conception, design, execution and interpretation of the data being published, wrote the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Other contributions to the work, such as providing of reagents or analytic tools, should be listed in the Acknowledgements. Ghostwriting and guest-authorship are forbidden. In case of detecting ghost written manuscripts, actions will be taken involving both the submitting authors and the participants involved. The corresponding author must have obtained permission from all authors for the submission of each version of the paper and for any change in authorship. Submission of a paper that has not been approved by all authors may result in immediate rejection.

Article Information and Declarations

These specific elements should be provided in dedicated sections of the submission panel; they are available according to the type of article. Please, do not include these elements in the main text. More information on particular items is provided in the Author Guidelines panel.

Acknowledgments

The authors may wish to express their thanks to those who contributed to the work but could not be co-authors of the manuscript. Sources of any support for the work in the form of grants, equipment, or drugs presented in the article should be listed as funding.

Author contributions

Please, describe the contribution of all co-authors to the final manuscript.

Funding

Please, highlight any funding that you may have received for the reported research or state that no funding, grants, or other support was received.

Availability of data and materials

Please, indicate that original contributions presented in the study are included in the article (and as Supplementary Material, if applicable) and that further inquiries can be directed to the corresponding author.

Ethics approval and consent to participate

Please, if applicable state that the study was reviewed and approved by an Ethics Committee and that patients/participants provided their written informed consent to participate in this study. If not applicable, please explain why ethical approval and/or consent were not required.

Competing interests

Any possible conflicts of interest regarding the submitted article should be described for each author, or authors should declare they have no conflict of interest related to the submitted manuscript.

Supplementary Material

If applicable: the Supplementary Material for this article can be found online at: (link will be provided by an Editor).

Table I. Elements of <Article Information and Declarations> according to submission type

Author statement

Article Information and Declarations

These specific elements should be provided in dedicated sections of the submission panel; they are available according to the type of article. Please, do not include these elements in the main text. More information on particular items is provided in the Author Guidelines panel.

Acknowledgments

The authors may wish to express their thanks to those who contributed to the work but could not be co-authors of the manuscript. Sources of any support for the work in the form of grants, equipment, or drugs presented in the article should be listed as funding.

Author contributions

Please, describe the contribution of all co-authors to the final manuscript.

Funding

Please, highlight any funding that you may have received for the reported research or state that no funding, grants, or other support was received.

Availability of data and materials

Please, indicate that original contributions presented in the study are included in the article (and as Supplementary Material, if applicable) and that further inquiries can be directed to the corresponding author.

Ethics approval and consent to participate

Please, if applicable state that the study was reviewed and approved by an Ethics Committee and that patients/participants provided their written informed consent to participate in this study. If not applicable, please explain why ethical approval and/or consent were not required.

Competing interests

The Journal requires that any possible conflicts of interest regarding the submitted article should be described for each author, or authors should declare they have no conflict of interest related to the submitted manuscript. Potential sources of conflict of interest include, but are not limited to: affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. The existence of a conflict of interest does not prevent publication. It is responsibility of the corresponding author to review this policy with all authors and collectively disclose with the submission all relevant business relationships and any others that might be pertinent.

Supplementary Material

If applicable: the Supplementary Material for this article can be found online at: (link will be provided by an Editor).

 Table I. Elements of according to submission type

Already have a Username/Password for Folia Histochemica et Cytobiologica?

Registration and login are required to submit items online and to check the status of current submissions.

By sending the manuscript with figures and charts the author (authors) declares (declare) it has been neither published nor submitted to the Editorial Board of any other journal (not including the abstracts 400 words or less). Moreover, it is assumed that the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploitation) are automatically and free-of-charge transferred to the Polish Histochemical and Cytochemical Society, under condition that those materials are accepted for publication.

The authors accept the fact, that the work will not be published anywhere and in any language without the prior written consent of the owner of the copyrights, i.e. the Polish Histochemical and Cytochemical Society.

Independently to the formerly mentioned effects, author (authors) due to release  form the responsibilities to the third parties, shall (should) attach the cover letter to the manuscript. The cover letter shall contain declaration of the author (authors) confirming formerly described facts and that all co-authors of the manuscript agree for the publication. Moreover the author (authors) confirm that they have acquaint themselves with the editorial policy in “Folia Histochemica et Cytobiologica” and they oblige to respect the policy. The reward for sending the manuscript is publication in the journal.

The written permission from the previous Polish Histochemical and Cytochemical Society for the reprint should be enclosed to the materials (pictures, photos, figures, etc.) that have been printed previously. If the data presented in case reports, figures or in the text enable identification of the persons their written consent to the publication should be enclosed.

Any potential conflict of interest will be dealt with by the local court specific to the Polish Histochemical and Cytochemical Society.

Legal relations between the Polish Histochemical and Cytochemical Society and the author(s) are in accordance with Polish law and with international conventions binding to Poland. The legal bases to acquiring the copyright are article 921 section 3 sentence 3 of the civil code in connection with article 50 of the copyright law and related law as well as the international conventions binding to Poland.

© Polish Histochemical and Cytochemical Society

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Charges for manuscript publication

The cost of publication of accepted manuscript is 1200 Euro.